We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App





DYNEX Demonstrates DYNABLOT Automatic Analyzer for Immunoblot and Westernblot Methods

By LabMedica International staff writers
Posted on 19 Nov 2019
DYNEX Technologies (Prague, Czech Republic) demonstrated its DYNABLOT automatic analyzer for immunoblot and Western blot methods at this year's MEDICA, the world's largest annual medical technology trade fair, which took place from 18-21 November in Düsseldorf, Germany. More...
At the 2019 edition of MEDICA, more than 5,000 exhibitors from 70 countries presented their newest products and ideas. The event also drew more than 120,000 trade visitors from over 170 countries.

The increasing digitalization of processes in the healthcare economy was a major topic at this year's MEDICA and was represented by exhibitors at the event as well as reflected in the programs of the accompanying conferences and forums. A new feature this year was a new allocation of themes in the exhibition halls. Due to the increasing convergence of software and hardware, especially in the field of medical technology, the halls for the MEDICA segment of information and communication technology was moved to make it directly connected to the halls for medical technology and electromedicine. Manufacturers of surgical instruments were moved to halls that brought them thematically closer to providers of imaging technology (e.g. endoscopy) as well as complete solutions for modern hybrid operating rooms.

DYNEX, a supplier of laboratory equipment and related services, primarily focuses on the sale of instruments, diagnostics and other reagents for immunochemical, molecular-biological and microbiological laboratories. DYNEX specializes in the following methods: ELISA, immunoblot and Western blot, immunofluorescence assay (IFA), PCR, hybridization, electrophoresis, microarray, next-generation sequencing, lateral-flow immunoassay (LFIA), immunoprecipitation, cultivation and cell growth curves measurements.

At the 2019 edition of MEDICA, DYNEX demonstrated its DYNABLOT fully automated analyzer for immunoblot and Western blot methods. The system fully automates blot pro- cessing starting with samples being pipetted and finishes with camera image capture. Only insertion of samples in primary tubes and strips are required from an operator. The instrument is fitted with reagents peristaltic pumps located at its front for easy use and handling. The pumps are capable of running in reverse. It assists the functions “Antidrop” (no drops at the end of tubing during dispensing) and “Reagents saving” (aspiration of dead volume back to reagent bottles after last dis-pensing).

The mixing of strip content during incubation is assisted by rocking the strip plate. Slow, medium or fast rocking speeds can be selected. Used liquid media is removed by an integrated vacuum pump and then directed to a waste bottle with a level sensor. Its compact dimensions (800 x 500 x 540 mm), weight (35 kg), and very quiet running make it friendly to laboratory environments.

Related Links:
Dynex Technologies


Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
Online QC Software
Acusera 24•7
Thyroid Test
Anti-Thyroid EIA Test
CMV CLIA Diagnostic
CLIA CMV IgA Screen Group
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: The approach supports myocardial infarction diagnosis in resource-limited settings by reducing delays between clinical suspicion and biochemical confirmation (Image Credit: Adobe Stock)

Portable Troponin Assay Brings Heart Attack Diagnosis Closer to Patients

Timely confirmation of myocardial infarction often depends on laboratory testing that may not be immediately available at the point of care. This gap between clinical suspicion and definitive evidence... Read more

Molecular Diagnostics

view channel
Image: The two new tests are used with the LightCycler 480 and LightCycler PRO instruments (Photo courtesy of Roche)

New PCR Assays Expand Cyclospora Testing for Outbreak Surveillance

Cyclospora cayetanensis, a food- and waterborne intestinal parasite, can cause prolonged diarrhea, fatigue, and abdominal cramping, placing added strain on urgent care and emergency departments during outbreaks.... Read more

Immunology

view channel
Image: Graphical Abstract (Morgane Fournier et al., Cell (2026). DOI: 10.1016/j.cell.2026.04.013)

Study Reveals Immune Mechanism Driving Severe COVID-19 Progression

Severe COVID-19 has highlighted gaps in understanding of early antiviral responses, particularly why some patients deteriorate despite timely care. Type I interferons are central to host defense, yet their... Read more

Microbiology

view channel
Image: An innovative countywide program in Taiwan combines risk-based screening with decentralized community care to improve hepatitis C detection and treatment (Image Credit: iStock)

Precision Screening Helps Close Hepatitis C Diagnosis and Treatment Gaps

Hepatitis C remains a leading cause of cirrhosis and liver cancer, yet many infections go undiagnosed or untreated because health systems fail to reach those at greatest risk. Although highly effective... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.